https://www.avient.com/sites/default/files/2020-08/silicone-dispersion-technologies-brochure.pdf
Additive technologies include:
• Heat stabilizers
• Acid acceptors
• Mold release agents
• Phosphorescent
• Flame retardant
• Tensile modifiers
• Antioxidants
• Peroxides
• Viscosity modifiers
• Electrically conductive systems
• Thermally conductive systems
• Radio-opacity
• Self-bond
TYPICAL USES
Silicone dispersions are used in a wide range
of applications:
• Automotive – spark plug boots, ignition cables,
gaskets/seals, O-rings, overmolded parts
• Rollers – industrial, copiers
• Fabric Coating – welding curtains, air bags, belts
• Cookware – bakeware, spatulas, gloves
• Consumer Goods – goggles, glasses,
cell phone covers, grips
• Healthcare – sterilization pads, catheters, grips,
tubing, grommets, prosthesis
• Military and Aerospace – gas masks, clip straps,
jet starter hose
• Wire & Cable/Power Transmission – jackets,
sleeves, insulators
• Infant Care – nipples/pacifiers, toys
• Extrusion – architectural, O-ring cords, gaskets,
spacers, profiles
Manufacturing locations:
Massillon, OH, USA
LaPorte, IN, USA
Eindhoven, Netherlands
Learn more about our silicone dispersions
at 1.844.4AVIENT (1.844.428.4368) or visit
www.avient.com.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Gabelli%2520%2526%2520Company%2520Specialty%2520Chemical%2520Conference.pdf
POLYONE CORPORATION 3
Use of Non-GAAP Measures
This presentation includes the use of both GAAP (generally accepted accounting
principles) and non-GAAP financial measures.
Addressable market exceeds $40 billion
Strong performance demonstrates that our strategy and execution
are working
Megatrends and emerging opportunities align with strengths
Innovation and services provide differentiation, incremental pricing
power and competitive advantage
Strategic balance between reinvestment for growth and returning
cash to shareholders
Strong and proven management team driving growth and
performance
18 POLYONE CORPORATION
Segment Highlights
POLYONE CORPORATION 19
2016 Revenue: $0.8 Billion
At a Glance: Color, Additives & Inks
Key Applications
2016 Revenue by Industry Expanding Profits
1.7%
4.6% 5.1% 5.5%
7.2% 8.1%
9.7%
12.2%
14.7%
16.7% 16.0%
20%+
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2020
Operating Income % of Sales
Platinum
Vision
United
States
45%
Europe
33%
Asia
15% Latin
America
5%
Canada
2%
Packaging
30%
Industrial
15%
W & C
10%
B & C
10% Textiles
9%
Transportation
9%
Consumer
7%
Healthcare
6%
Appliance
2%
E & E
2%
POLYONE CORPORATION 20
2016 Revenue: $0.6 Billion
At a Glance: Specialty Engineered Materials
2016 Revenue by Industry Expanding Profits
1.1% 1.3%
3.4%
5.1%
9.6%
8.0% 8.6% 9.3%
12.1%
14.7% 14.3%
20%+
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2020
Operating Income % of Sales
Platinum
Vision
Consumer
19% Transportation
19%
E & E
15%
W & C
15%
Healthcare
11%
Industrial
8%
Packaging
7%
Appliance
3%
B & C
3%
United
States
51%
Europe
27%
Asia
20%
Canada
2%
Key Applications
POLYONE CORPORATION 21
2016 Revenue: $0.4 Billion
At a Glance: Designed Structures & Solutions
2016 Revenue by Industry Expanding Profits
1.4%
5.6%
7.3%
3.0%
8-10%
-0.9%
2012 2013 2014 2015 2016 2020
Operating Income % of Sales
Platinum
Vision
Transportation
27%
Industrial
21%
Packaging
21%
B & C
11% Healthcare
8%
Consumer
8%
Appliance
3%
E & E
1%
Key Applications
United
States
95%
Canada
5%
http://www.google.com/url?
Adjusted EPS attributable to PolyOne common shareholders is calculated as follows:
2009* 2010 2011 2012 2013 2014 2015 2016
Net income attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 165.2
Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — —
Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 35.5
Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (20.7)
Adjusted net income attributable to PolyOne common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 180.0
Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6
Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.13
Adjusted operating income is calculated as follows:
2006* 2016
Operating income $ 233.6 $ 281.9
Special items (1) (39.1) 35.3
Joint venture equity earnings (107.0) 0.0
Adjusted operating income $ 87.5 $ 317.2
* Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation
https://www.avient.com/sites/default/files/2021-10/avnt-q3-2021-earnings-presentation_0.pdf
Avient acquired the Clariant Color business on July 1, 2020 (the “Acquisition Date”).
This
innovation drives performance and is
reflective of consistent, strategic
investments in technology and people
Clariant Color business
acquired July 1, 2020
10
30
40
14
25
22
35
19
18
41
Current Additional share needed to reach 2025 target
BRAND OWNERS COMMITTED TO INCREASING
USE OF RECYCLED MATERIALS
8
Brand Owner 1
Brand Owner 3
Brand Owner 2
Brand Owner 7
Brand Owner 4
Brand Owner 10
Brand Owner 6
Brand Owner 11
Brand Owner 5
Brand Owner 8
Brand Owner 9
Brand Owner 12
Brand Owner 13
Percent recycled plastic used:
(examples and not exhaustive)
(1) Latest year reported.
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
22
Capex / Revenue
2021E (%)
AVIENT IS ASSET LIGHT
Avient Specialty
Other
3 3 3
3 3
5 5 5 5
6
8
nt
nt
(
xc
l.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520–%2520Goldman%2520Sachs%2520Conference%25202015.pdf
PolyOne Corporation Page 3
Use of Non-GAAP Measures
This presentation includes the use of both GAAP (generally accepted accounting
principles) and non-GAAP financial measures.
S&P 500
PolyOne Corporation Page 9
2006 Q1 2015 2020
“Where we were” “Where we are” Platinum Vision
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 16.2% 20%+
Global Specialty Engineered
Materials 1.1% 16.3% 20%+
Designed Structures & Solutions 1.4% (2012) 2.7% 12 – 14%
Performance Products &
Solutions 5.5% 6.5% 10 – 12%
Distribution 2.6% 5.9% 6.5 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 69% 80%+
3) ROIC 5.0% 11.4% 15%
4) Adjusted EPS Growth N/A
22 Consecutive
Quarters of
EPS Growth
Double Digit
Expansion
Proof of Performance & 2020 Goals
PolyOne Corporation Page 10
Platinum Vision: Pathway to Accelerated Growth
Organic
Sales Growth
Margin
Expansion
Share
Repurchases
Acquisitions
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2014
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
27%
2006 2014
Specialty Platform
Gross Margin %
20%
44%
2006 2014
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 12
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 13
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
6
9
7
3
5
12
5 3 2
8
4
2
4
3
1
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 14 8 18 12 22 74
Addressable Market
($ millions) $700 $600 $600 $1,900
PolyOne Corporation Page 14
60%
98%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 Q1 2015
Pension Funding**
As of March 31, 2015
Debt Maturities & Pension Funding
Net Debt / EBITDA* = 2.1x
$49
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2015
($ millions)
Coupon Rate: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 3/31/2015
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
~75% of capital
expenditures fund
growth initiatives Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
Synergy opportunities
Adjacent material
solutions
Repurchased over
500k shares in Q1
2015
Repurchased 11.8
million shares since
early 2013
8.2 million shares are
available for
repurchase under the
current authorization
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
1) Special items are a non-GAAP financial measure.
https://www.avient.com/resources/safety-data-sheets?page=3305
5209 FPL 20 NATURAL 1
GRAY PET 3
PE GREEN HOSE
https://www.avient.com/investor-center/news/polyone-announces-third-quarter-2017-results
$3 million to $4 million
1)
Attachment 4
https://www.avient.com/sites/default/files/2024-08/Avient-2023-Sustainability-Report_6.pdf
Scope 3 emissions are many
times greater than our combined Scope 1 and 2 emissions.
HAPs: 6.77 MT
Metrics—Planet Metrics Page 77
Energy Management
(1) Total energy consumed, (2) percentage grid electricity, (3)
percentage renewable, (4) total self-generated energy RT-CH-130a.1
1.
Total energy: 2,144,770 GJ
2. % Grid electricity: 77.53%
3. % renewable electricity: 62%
4.
https://www.avient.com/sites/default/files/2022-05/MEVOPUR LQ for Silicone Elastomers_CN.pdf
MEVOPUR LQ for Silicone Elastomers_CN5.17-1
MEVOPUR™ LQ
应用于硅橡胶的液体着色剂和添加剂母粒
应用公告
硅橡胶由于其独特的物理特性组合,例如强度、
耐受度及灵活性等,同时作为一种通过最多生物
相容性及低致敏性测试的聚合物之一,成为了多
种医疗应用的首选材料。
可根据要求提供多种定制化
颜色解决方案
根据ISO 13485/GMP质量体系生产,并拥有变
更控制管理
原材料红外光谱分析和常规批次检测
根据ISO 10993第18部分对正己烷、异丙醇及
水中的可萃取性进行评估
法规支持
原材料根据ISO 10993-1和USP第、
章(VI类)对原材料进行生物评估的预测试
向FDA提交所有标准颜色的DMF/MAF文件
应用
医疗器械,如导管和连接器、注射器针头及无
针连接器
与皮肤接触设备,如可穿戴设备或医疗器械的
柔软触感表面
MEVOPUR LQ 配方可用于要求严苛的应用,包
括:
MEVOPUR™-LQ 不透明红(PMS198C)
产品编号:FZ3M415008
MEVOPUR™-LQ 透明红
产品编号:FZ3M415009
MEVOPUR™-LQ 不透明蓝(PMS292C)
产品编号:FZ5M415008
MEVOPUR™-LQ 透明蓝
产品编号:FZ5M415009
MEVOPUR™-LQ 不透明黄(PMS1205C)
产品编号:FZ1M415005
MEVOPUR™-LQ 透明黄
产品编号:FZ1M415006
MEVOPUR™-LQ 不透明绿(PMS346C)
产品编号:FZ6M415008
MEVOPUR™-LQ 透明绿
产品编号:FZ6M415009
MEVOPUR™-LQ 不透明紫(PMS2655C)
产品编号:FZ4M415003
MEVOPUR™-LQ 透明紫
产品编号:FZ4M415004
定制化选择
也可以根据您的需求
定制颜色,
请联系我们。
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:
(1) 接触人体组织或体液长达30天或更长时间;
(2)“整形”(整容或重建)手术;
(3) 生殖植入物或任何节育器械;或者
(4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/2025-05/Avient Announces First Quarter 2025 Results_0.pdf
This
translates to 4% adjusted EPS growth, excluding the unfavorable impact of foreign exchange.
See Attachment 3 for a definition and summary of special items.
See
Attachment 3 for a definition and summary of special items.
https://www.avient.com/resources/safety-data-sheets?page=3939
X ET-8303-1C
X ET-8303-1B
SPOUT CAP Q728-3-2 GREY 3 TPE